Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nizar M Tannir

Showing results (1-10 of 297) with videos related to

Pageof 30
Sort By:
Cancer Journal (Sudbury, Mass.)|October 7, 2008
Adjuvant and neoadjuvant therapy in renal cell carcinomaEric Jonasch, Nizar M Tannir
Targeted Oncology|July 14, 2010
Targeted therapy for locally advanced renal cell carcinomaEric Jonasch, Nizar M Tannir
Urology|September 5, 2017
Editorial CommentAmishi Y Shah, Nizar M Tannir
Cancer Treatment Reviews|September 3, 2018
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinomaMichael B Atkins, Nizar M Tannir
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 9, 2011
Treatment-related optimism protects quality of life in a phase II clinical trial for metastatic renal cell carcinomaKathrin Milbury, Nizar M Tannir, Lorenzo Cohen
The American Journal of Surgical Pathology|February 4, 2012
Expression of OCT3/4 in renal medullary carcinoma represents a potential diagnostic pitfallPriya Rao, Nizar M Tannir, Pheroze Tamboli
Hematology/Oncology Clinics of North America|May 27, 2023
Renal Cell Carcinoma of Variant Histology: Biology and TherapiesPavlos Msaouel, Giannicola Genovese, Nizar M Tannir
Current Oncology Reports|March 2, 2017
Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell CarcinomaNizar M Tannir, Gisela Schwab, Viktor Grünwald
Cancer Journal (Sudbury, Mass.)|September 18, 2020
The Immunotherapy Revolution in Kidney Cancer Treatment: Scientific Rationale and First-Generation ResultsElshad Hasanov, Jianjun Gao, Nizar M Tannir
JCO Precision Oncology|February 17, 2022
Metabolic Derangements in Succinate Dehydrogenase B-Mutated Renal-Cell Carcinomas: More Than Meets the Eye?Pavlos Msaouel, Gabriel G Malouf, Nizar M Tannir
Pageof 30

Showing results (1-10 of 297) with videos related to

Sort By:
Pageof 30
Cancer Journal (Sudbury, Mass.)|October 7, 2008
Adjuvant and neoadjuvant therapy in renal cell carcinomaEric Jonasch, Nizar M Tannir
Targeted Oncology|July 14, 2010
Targeted therapy for locally advanced renal cell carcinomaEric Jonasch, Nizar M Tannir
Urology|September 5, 2017
Editorial CommentAmishi Y Shah, Nizar M Tannir
Cancer Treatment Reviews|September 3, 2018
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinomaMichael B Atkins, Nizar M Tannir
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 9, 2011
Treatment-related optimism protects quality of life in a phase II clinical trial for metastatic renal cell carcinomaKathrin Milbury, Nizar M Tannir, Lorenzo Cohen
The American Journal of Surgical Pathology|February 4, 2012
Expression of OCT3/4 in renal medullary carcinoma represents a potential diagnostic pitfallPriya Rao, Nizar M Tannir, Pheroze Tamboli
Hematology/Oncology Clinics of North America|May 27, 2023
Renal Cell Carcinoma of Variant Histology: Biology and TherapiesPavlos Msaouel, Giannicola Genovese, Nizar M Tannir
Current Oncology Reports|March 2, 2017
Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell CarcinomaNizar M Tannir, Gisela Schwab, Viktor Grünwald
Cancer Journal (Sudbury, Mass.)|September 18, 2020
The Immunotherapy Revolution in Kidney Cancer Treatment: Scientific Rationale and First-Generation ResultsElshad Hasanov, Jianjun Gao, Nizar M Tannir
JCO Precision Oncology|February 17, 2022
Metabolic Derangements in Succinate Dehydrogenase B-Mutated Renal-Cell Carcinomas: More Than Meets the Eye?Pavlos Msaouel, Gabriel G Malouf, Nizar M Tannir
Pageof 30